Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for the treatment of conditions associated with DGAT1 activity

Compounds for the treatment of conditions associated with DGAT1 activity

US Patent 8987459 · Granted Mar 24, 2015

Estimated economic value: $11,085,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tebipenem pivoxil immediate and modified release oral dosage forms2025
Tebipenem pivoxil crystalline forms, compositions including the same, methods of2024
Compounds for RNA capping and uses thereof2024
High dosage tebipenem pivoxil tablet formulation2024
Aspirin-mimetic antioxidants for treatment of age-related cataract2023
Tebipenem pivoxil crystalline forms, compositions including the same, methods of2023
Aromatic heterocyclic compound, and pharmaceutical composition and use thereof2023
Crystalline forms of a triazolopyrimidine compound2023
Crystalline forms of a triazolopyrimidine compound2021
Processes and intermediates for the preparation of 1′-substituted carba-nucleosi2021
Tebipenem pivoxil crystalline forms, compositions including the same, methods of2021
Processes and intermediates for the preparation of 1′-substituted carba-nucleosi2018